FDA Approved: PIRFENIDONE — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved an Abbreviated New Drug Application for pirfenidone (Novadoz Pharmaceuticals LLC), a generic version of the IPF therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

ORIG AP for PIRFENIDONE (PIRFENIDONE)